Plain-English translation of NCT05527470 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether combining chemotherapy with radiation therapy works better than radiation alone for people with advanced nasopharyngeal cancer. All participants will first receive chemotherapy (using gemcitabine and ) for about 9 weeks to shrink the tumor. Then, half will receive radiation therapy alone, while the other half will receive radiation therapy along with additional chemotherapy to see which approach gives better results.
Nasopharyngeal cancer is a serious illness, and doctors want to find the best way to treat it. This trial is trying to determine whether adding extra chemotherapy during radiation helps patients live longer and healthier lives compared to radiation treatment by itself.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will first receive three cycles of chemotherapy over about 9 weeks as an outpatient. Then you will be randomly assigned to one of two groups: one group receives radiation therapy alone (given 5 days a week for 6–7 weeks), and the other receives the same radiation therapy plus additional chemotherapy given every 3 weeks during the radiation period. Throughout treatment, you will have regular blood tests and imaging scans to monitor your health and how well the cancer is responding.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China